[HTML][HTML] The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion

P De Cicco, G Ercolano, A Ianaro - Frontiers in immunology, 2020 - frontiersin.org
Suppression of antitumor immune responses is one of the main mechanisms by which tumor
cells escape from destruction by the immune system. Myeloid-derived suppressor cells …

[HTML][HTML] Prostaglandin E2 and cancer: insight into tumor progression and immunity

F Finetti, C Travelli, J Ercoli, G Colombo, E Buoso… - Biology, 2020 - mdpi.com
Simple Summary Inflammation is assessed as a hallmark of cancer and it is now widely
recognized that there exists a direct causal link between inflammation and tumors. Among …

Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review

K Mortezaee, M Najafi, B Farhood, A Ahmadi, Y Potes… - Life sciences, 2019 - Elsevier
Radio-and chemotherapy are the most common cancer treatment modalities. They cause
acute and late side effects on normal tissues, which is a burden for delivery of a high dose of …

[HTML][HTML] COX-2 as a potential biomarker and therapeutic target in melanoma

DV Tudor, I Bâldea, M Lupu, T Kacso… - Cancer biology & …, 2020 - ncbi.nlm.nih.gov
With a constantly increasing incidence, cutaneous melanoma has raised the need for a
better understanding of its complex microenvironment that may further guide therapeutic …

[HTML][HTML] Lipid metabolic reprogramming: Role in melanoma progression and therapeutic perspectives

L Pellerin, L Carrié, C Dufau, L Nieto, B Ségui… - Cancers, 2020 - mdpi.com
Simple Summary Melanoma is a devastating skin cancer characterized by an impressive
metabolic plasticity. Melanoma cells are able to adapt to the tumor microenvironment by …

[HTML][HTML] COX-2 expression positively correlates with PD-L1 expression in human melanoma cells

G Botti, F Fratangelo, M Cerrone, G Liguori… - Journal of Translational …, 2017 - Springer
Background The resistance to PD-1/PD-L1 inhibitors for the treatment of melanoma have
prompted investigators to implement novel clinical trials which combine immunotherapy with …

Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia

T Stark, J Ruda-Kucerova, FA Iannotti, C D'Addario… - …, 2019 - Elsevier
In agreement with the neurodevelopmental hypothesis of schizophrenia, prenatal exposure
of rats to the antimitotic agent methylazoxymethanol acetate (MAM) at gestational day 17 …

[HTML][HTML] The phenomenon of phototoxicity and long-term risks of commonly prescribed and structurally diverse drugs

AE Davis, GE Kennelley, T Amaye-Obu… - … of photochemistry and …, 2024 - Elsevier
Photosensitivity to structurally diverse drugs is a common but under-reported adverse
cutaneous reaction and can be classified as phototoxic or photoallergic. Phototoxic …

Current analytical approaches in diagnosis of melanoma

A Eftekhari, E Ahmadian, S Salatin, S Sharifi… - TrAC Trends in …, 2019 - Elsevier
This review aims to explore applied variety methods for prognosis and diagnosis melanoma
in early stages. The role of skin self-examination in early detection, the use of dreamscape …

The impact of nonsteroidal anti‐inflammatory drugs, beta blockers, and metformin on the efficacy of anti‐PD‐1 therapy in advanced melanoma

DY Wang, JL McQuade, RR Rai, JJ Park, S Zhao… - The …, 2020 - academic.oup.com
Anti–programmed cell death protein‐1 (anti‐PD‐1) therapy has greatly improved outcomes
of patients with melanoma; however, many fail to respond. Although preclinical studies …